Marked alteration of glycemic profile surrounding lanreotide administration in acromegaly: A case report

Whether somatostatin analogs for acromegaly improve or worsen a patient's glycemic profile is controversial. A risk of hypoglycemia should be presumed, especially when patients receive insulin therapy, as the package inserts caution. However, a detailed clinical course of such a case has never...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Diabetes Investig
Main Authors: Tanaka, Sho, Haketa, Akira, Yamamuro, Shun, Suzuki, Toshiko, Kobayashi, Hiroki, Hatanaka, Yoshinari, Ueno, Takahiro, Fukuda, Noboru, Abe, Masanori, Yoshino, Atsuo, Soma, Masayoshi
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2017
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5754526/
https://ncbi.nlm.nih.gov/pubmed/28390105
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12675
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki